6533b7d5fe1ef96bd1263e4d

RESEARCH PRODUCT

Survival with low- and high-flux dialysis

Emilio Sánchez-álvarezMinerva Rodríguez-garcíaAnibal FerreiraDrasko PavlovicJorge B. Cannata-andíaJosé L. Fernández-martínCosmos GroupJosé Luis MotellónMatthew TurnerJulien ChaussyBart MolemansWal ZaniFrancesco LocatelliDylan RosserBastian DehmelBruno FouquerayBrian BradburyJohn AcquavellaJennifer HollowellDave CarterPhil HollandAna BañosCaroline MattinCarmine ZoccaliCathy CritchlowJoseph KimCharlotte LewisAntonia PanayiMargit HemetsbergerStephen CroftPhilippe JaegerPrisca MuehlebachJane BlackburnEsther ZumstegAlejandro Martín-maloAndrey GurevichSilvia RodríguezAngel PérezPau FanerIrantzu IzcoSusana TraseiraCarmen CastroJavier MorenoDavid CalleFrancesca PieracciniJürgen FlögeMarkus KettelerGerard LondonJosé L. GórrizBoleslaw Rutkowski

subject

medicine.medical_specialtymedicine.medical_treatmentPopulation030232 urology & nephrology610030204 cardiovascular system & hematologyPeritoneal dialysis03 medical and health sciences0302 clinical medicineInternal medicinemedicineddc:610AcademicSubjects/MED00340educationDialysisTransplantationeducation.field_of_studychronic haemodialysisbusiness.industryMortality rateHazard ratioOriginal ArticlesmortalityNephrologyRelative riskPropensity score matchingdialysismortality riskHemodialysisbusinessdialysis membranes

description

The National Program of I + D + I 2008–2011 and Instituto de Salud Carlos III (ISCIII), the ISCIII Retic REDinREN (RD06/0016/1013, RD12/0021/0023 and RD16/ 0009/0017), the ISCIII (ICI14/00107, PI17/00384 and PI20/00633), Fondo Europeo de Desarrollo Regional (FEDER), Plan Estatal de I + D + I 2013–2016, Plan de Ciencia, Tecnología e Innovación 2013–2017 y 2018–2022 del Principado de Asturias (GRUPIN14-028, IDI-2018-000152) (...)

10.1093/ckj/sfaa233http://hdl.handle.net/10651/63072